3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, B-Cell
2
Cytokine Release Syndrome
2
Burkitt Lymphoma
2
Pancreatic Neoplasms
1
Neurotoxicity Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Early Stage Triple Negative ER Low Breast Cancer
1
Disease Progression
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Capecitabine
42
Oxaliplatin
39
Fluorouracil
29
Leucovorin
23
Radiotherapy
22
Cetuximab
15
Bevacizumab
15
Irinotecan
13
Nivolumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Drug Therapy
9
Surgical Procedures, Operative
8
Folfox protocol
8
pembrolizumab
7
Radiotherapy, Intensity-Modulated
7
Chemoradiotherapy
7
Biopsy
7
trifluridine tipiracil drug combination
6
Radiation
6
tislelizumab
5
sintilimab
5
regorafenib
5
dehydroftorafur
5
X-Rays
5
Surveys and Questionnaires
5
Sigmoidoscopy
5
Endoscopy
5
Consolidation Chemotherapy
5
spartalizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Interleukin 1 Receptor Antagonist Protein
×
1 year
×
Clear all
No trials found.